This paper is in the following e-collection/theme issue:

Patient-Reported Outcome Measures (PROMs) (275) Chemotherapy and Side Effects Management (52) Skin Cancer and Melanoma Prevention (110)

Published on in Vol 22, No 4 (2020): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/14896, first published .
Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences

Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences

Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences

Authors of this article:

Lærke K Tolstrup1, 2 Author Orcid Image ;   Helle Pappot3 Author Orcid Image ;   Lars Bastholt1, 2 Author Orcid Image ;   Ann-Dorthe Zwisler1, 4 Author Orcid Image ;   Karin B Dieperink1, 2 Author Orcid Image
Article Authors Cited by (22) Tweetations (15) Metrics

Journals

  1. Jamieson L, Forster M, Zaki K, Mithra S, Alli H, O’Connor A, Patel A, Wong I, Chambers P. Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study. BMC Cancer 2020;20(1) View
  2. Tolstrup L, Bastholt L, Dieperink K, Möller S, Zwisler A, Pappot H. The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial. Journal of Patient-Reported Outcomes 2020;4(1) View
  3. Wickramasekera N, Taylor S, Lumley E, Gray T, Wilson E, Radley S. Can electronic assessment tools improve the process of shared decision-making? A systematic review. Health Information Management Journal 2023;52(2):72 View
  4. Sauer C, Krauß J, Jäger D, Zschäbitz S, Haag G, Walle T, Sauer S, Kiermeier S, Friederich H, Maatouk I. eHealth intervention to manage symptoms for patients with cancer on immunotherapy (SOFIA): a study protocol for a randomised controlled external pilot trial. BMJ Open 2021;11(7):e047277 View
  5. Tawfik B, Burgess E, Kosich M, Jaffe S, Guest D, Brown-Glaberman U, Pankratz V, Sussman A. Patient, provider, and nurse preferences of patient reported outcomes (PRO) and side effect management during cancer treatment of underrepresented racial and ethnic minority groups, rural and economically disadvantaged patients: a mixed methods study. Cancer Causes & Control 2022;33(9):1193 View
  6. Tolstrup L, Pappot H, Bastholt L, Möller S, Dieperink K. Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial. Journal of Patient-Reported Outcomes 2022;6(1) View
  7. Zhang L, Lu Y. Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors. Asia-Pacific Journal of Oncology Nursing 2021;8(6):596 View
  8. Fraterman I, Glaser S, Wilgenhof S, Medlock S, Mallo H, Cornet R, van de Poll-Franse L, Boekhout A. Exploring supportive care and information needs through a proposed eHealth application among melanoma patients undergoing systemic therapy: a qualitative study. Supportive Care in Cancer 2022;30(9):7249 View
  9. Wickline M, Wolpin S, Cho S, Tomashek H, Louca T, Frisk T, Templin J, Loechl A, Goff B, Berry D. Usability and acceptability of the electronic self-assessment and care (eSAC) program in advanced ovarian cancer: A mixed methods study. Gynecologic Oncology 2022;167(2):239 View
  10. Zhang L, Zhang X, Shen L, Zhu D, Ma S, Cong L. Efficiency of Electronic Health Record Assessment of Patient-Reported Outcomes After Cancer Immunotherapy. JAMA Network Open 2022;5(3):e224427 View
  11. Møller P, Pappot H, Bernchou U, Schytte T, Mortensen Z, Brúnni M, Dieperink K. Feasibility, usability and acceptance of weekly electronic patient-reported outcomes among patients receiving pelvic CT- or online MR-guided radiotherapy – A prospective pilot study. Technical Innovations & Patient Support in Radiation Oncology 2022;21:8 View
  12. AlQuzi F, Bowers A, Alexander K, Bradford N. Assessment of Symptoms and Adverse Events Related to Immunotherapy in Patients With Cancer: An Integrative Review. Journal of Pain and Symptom Management 2023;66(1):e69 View
  13. Tolstrup L, Als A, Carus A, Dahlrot R, Dohn L, Holländer-Mieritz C, Taarnhøj G, Pappot H. The iBLAD app protocol – a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care. Acta Oncologica 2023;62(3):329 View
  14. Lopez C, Teggart K, Ahmed M, Borhani A, Kong J, Fazelzad R, Langelier D, Campbell K, Reiman T, Greenland J, Jones J, Neil-Sztramko S. Implementation of electronic prospective surveillance models in cancer care: a scoping review. Implementation Science 2023;18(1) View
  15. Lai-Kwon J, Cohen J, Lisy K, Rutherford C, Girgis A, Basch E, Jefford M. The Feasibility, Acceptability, and Effectiveness of Electronic Patient-Reported Outcome Symptom Monitoring for Immune Checkpoint Inhibitor Toxicities: A Systematic Review. JCO Clinical Cancer Informatics 2023;(7) View
  16. Laitio A, Giunti G, Halonen R. Perceived Barriers and Facilitators in Using Patient-Reported Outcome Systems for Cancer Care: Systematic Mapping Study. JMIR Cancer 2023;9:e40875 View
  17. Govindaraj R, Agar M, Currow D, Luckett T. Assessing Patient-Reported Outcomes in Routine Cancer Clinical Care Using Electronic Administration and Telehealth Technologies: Realist Synthesis of Potential Mechanisms for Improving Health Outcomes. Journal of Medical Internet Research 2023;25:e48483 View
  18. van Acker J, Maenhout L, Compernolle S, Albert S. Older Adults’ User Engagement With Mobile Health: A Systematic Review of Qualitative and Mixed-Methods Studies. Innovation in Aging 2023;7(2) View
  19. Pappot H, Taarnhøj G, Bentsen L, Friis R, Bæksted C, Christiansen M, Holländer-Mieritz C, Møller P, Rasmussen I, Lund-Jacobsen T, Stormoen D, Tolstrup L. Patient-reported outcomes used actively in cancer patients undergoing antineoplastic treatment: A mini-review of the Danish landscape. Computational and Structural Biotechnology Journal 2024;24:23 View
  20. Yip R, Arnolda G, Lamprell K, Nic Giolla Easpaig B, Chittajallu R, Delaney G, Olver I, Liauw W, Braithwaite J. Experience of patients considering or using checkpoint inhibitors in cancer treatment: a systematic review of qualitative research. Journal for ImmunoTherapy of Cancer 2024;12(1):e007555 View
  21. Tawfik B, Jacobson K, Brown-Glaberman U, Kosich M, Van Horn M, Nemunaitis J, Dayao Z, Pankratz V, Sussman A, Guest D. Developing questions to assess and measure patients’ perceived survival benefit from adjuvant endocrine therapy in breast cancer: a mixed methods pilot study. Clinical and Experimental Medicine 2024;24(1) View
  22. Sauer C, Zschäbitz S, Krauss J, Walle T, Haag G, Jäger D, Hiller K, Bugaj T, Friederich H, Maatouk I. Electronic health intervention to manage symptoms of immunotherapy in patients with cancer (SOFIA): Results from a randomized controlled pilot trial. Cancer 2024;130(14):2503 View